Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Liaison Interactive Invests $20 Million in Beijing's Dehaier Medical

publication date: Aug 22, 2016
Hangzhou Liaison Interactive Information Technology paid $20 million to acquire a 62% stake in Beijing's Dehaier Medical Systems, a medical device maker. Dehaier is transforming itself into a company that provides wearable sleep apnea products in China. Liaison Interactive, a mobile internet product company, will help develop and promote Dehaier's wearable medical devices. In 2014, Dehaier obtained China approval for the Morpheus OX sleep apnea system, developed with Israel's WideMed. More details....

Stock Symbols: (SHZ: 002280) (NSDQ: DHRM)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital